ClinicalTrials.Veeva

Menu

Effects of the Short-Chain Fatty Acids-Targeted Dietary Interventions on the Selected Autonomic Functions in Humans

W

Wroclaw Medical University

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Sodium butyrate supplementation
Dietary Supplement: Accessible starch supplementation
Dietary Supplement: Potato starch supplementation

Study type

Interventional

Funder types

Other

Identifiers

NCT06851039
STM.A090.20.110

Details and patient eligibility

About

Recent data feature short-chain fatty acids (SCFAs), products of gut microbial fermentation, as modulators of the blood pressure of the host. Such modulation may evoke (or arise from) changes in the autonomic reflexive mechanisms, but the link remains unexplored. Therefore, the study aims to explore potential relationship between the dietary intervention-induced changes in the SCFA plasma/fecal content and alterations in the sensitivity of the cardio-respiratory autonomic reflexes.

In this cross-over, placebo-controlled study, a group of healthy volunteers will undergo three distinct stages of a four-week dietary intervention, separated by at least two weeks of washout periods. During each stage, participants will receive one of the following interventions:

  • raw potato starch (a source of resistant type 2 starch, which is a substrate for the endogenous production of SCFAs)
  • sodium butyrate (a direct, exogenous source of this SCFA)
  • an amylase-accessible waxy maze starch (a placebo). Plasma and fecal SCFA concentrations will be measured, along with the comprehensive evaluation of the cardio-respiratory parameters and the sensitivity of the autonomic reflexive mechanisms.

Enrollment

14 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18-40 years

Exclusion criteria

  • chronic disease of the nervous, cardiovascular or respiratory system
  • disease of the digestive system, including history of the intestinal surgery, inflammatory bowel disease, celiac disease, lactose intolerance and other malabsorption disorders
  • blood pressure-lowering treatment within the past year
  • tobacco smoking within the past year
  • antibiotic/probiotic treatment and laxative/prokinetic usage in three months preceding the anticipated enrollment

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

14 participants in 3 patient groups, including a placebo group

potato starch
Experimental group
Treatment:
Dietary Supplement: Potato starch supplementation
sodium butyrate
Experimental group
Treatment:
Dietary Supplement: Sodium butyrate supplementation
accessible maze starch
Placebo Comparator group
Treatment:
Dietary Supplement: Accessible starch supplementation

Trial contacts and locations

1

Loading...

Central trial contact

Rafal Seredynski, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems